Merck Manual

Please confirm that you are a health care professional

honeypot link

Tumor Antigens

By

Dmitry Gabrilovich

, MD, PhD, Department of Pathology and Laboratory Medicine, Perelman School of Medicine at the University of Pennsylvania

Last full review/revision Nov 2020| Content last modified Nov 2020
Click here for Patient Education

Many tumor cells produce antigens, which may be released in the bloodstream or remain on the cell surface. Any molecule capable of being recognized by the immune system is considered an antigen. Antigens have been identified in most of the human cancers, including Burkitt lymphoma Burkitt Lymphoma Burkitt lymphoma is an aggressive B-cell lymphoma occurring in children and adults. Endemic (African), sporadic (non-African), and immunodeficiency-related forms exist. (See also Overview of... read more Burkitt Lymphoma , neuroblastoma Neuroblastoma Neuroblastoma is a cancer arising in the adrenal gland or less often from the extra-adrenal sympathetic chain, including in the retroperitoneum, chest, and neck. Diagnosis is confirmed by biopsy... read more , melanoma Melanoma Malignant melanoma arises from melanocytes in a pigmented area (eg, skin, mucous membranes, eyes, or central nervous system). Metastasis is correlated with depth of dermal invasion. With spread... read more Melanoma , osteosarcoma Osteosarcoma (osteogenic sarcoma) Primary bone tumors are much less common than metastatic bone tumors, particularly in adults. Primary bone tumors include multiple myeloma, osteosarcoma, adamantinoma, chondrosarcoma, chordoma... read more Osteosarcoma (osteogenic sarcoma) , renal cell carcinoma Renal Cell Carcinoma Renal cell carcinoma (RCC) is the most common renal cancer. Symptoms can include hematuria, flank pain, a palpable mass, and fever of unknown origin (FUO). However, symptoms are often absent... read more , breast cancer Breast Cancer Breast cancer most often involves glandular breast cells in the ducts or lobules. Most patients present with an asymptomatic mass discovered during examination or screening mammography. Diagnosis... read more Breast Cancer , prostate cancer Prostate Cancer Prostate cancer is usually adenocarcinoma. Symptoms are typically absent until tumor growth causes hematuria and/or obstruction with pain. Diagnosis is suggested by digital rectal examination... read more , lung carcinoma Lung Carcinoma Lung carcinoma is the leading cause of cancer-related death worldwide. About 85% of cases are related to cigarette smoking. Symptoms can include cough, chest discomfort or pain, weight loss... read more Lung Carcinoma , and colon cancer Colorectal Cancer Colorectal cancer is extremely common. Symptoms include blood in the stool and change in bowel habits. Screening using one of several methods is recommended for appropriate populations. Diagnosis... read more Colorectal Cancer . A key role of the immune system is detection of these antigens to permit subsequent targeting for eradication. However, despite their foreign structure, the immune response to tumor antigens varies and is often insufficient to prevent tumor growth (see also Host Response to Tumors Host Response to Tumors The immune response to foreign antigens consists of Humoral mechanisms (eg, antibodies) Cellular mechanisms (See also Tumor Antigens.) Most humoral responses cannot prevent tumor growth. However... read more ).

Tumor-associated antigens (TAAs) are relatively restricted to tumor cells.

Tumor-specific antigens (TSAs) are unique to tumor cells.

TSAs and TAAs typically are portions of intracellular molecules expressed on the cell surface as part of the major histocompatibility complex.

Suggested mechanisms of origin for tumor antigens include

  • Introduction of new genetic information from a virus (eg, human papillomavirus E6 and E7 proteins in cervical cancer)

  • Alteration of oncogenes or tumor suppressor genes by carcinogens, which result in formation of neoantigens (novel protein sequences or accumulation of proteins that are normally not expressed or are expressed at very low levels, such as ras or p53), either by generating the novel protein sequence directly or by inducing accumulation of these proteins

  • Development of missense mutations in various genes not directly associated with tumor suppressor or oncogenes and that cause appearance of tumor-specific neoantigens on the cell surface

  • Development of abnormally high levels of proteins that normally are present at substantially lower levels (eg, prostate-specific antigens, melanoma-associated antigens) or that are expressed only during embryonic development (carcinoembryonic antigens)

  • Uncovering of antigens normally buried in the cell membrane because of defective membrane homeostasis in tumor cells

  • Release of antigens normally sequestered within the cell or its organelles when tumor cells die

References

Click here for Patient Education
NOTE: This is the Professional Version. CONSUMERS: Click here for the Consumer Version
Professionals also read

Test your knowledge

Langerhans Cell Histiocytosis
A 10-year-old girl is brought to the clinic by her father because she has had pain in her right upper leg for the past 3 months. On physical examination, the patient is unable to bear weight on the limb. Edema of the upper leg and tenderness to palpation are noted. X-rays show 2 bone lesions with sharp margins and a punched-out appearance. Which of the following is the most appropriate definitive step in diagnosis?
Download the Manuals App iOS ANDROID
Download the Manuals App iOS ANDROID
Download the Manuals App iOS ANDROID
 

Also of Interest

 
TOP